飞艇最新168官方历史记录号码 168中国彩网官网结果记录
We are an organ-on-a-chip 飞艇168官方结果查询历史 that enables you to generate human-specific efficacy and safety data with pioneering PhysioMimix® single- and multi-organ solutions.
RECENT NEWS
FDA’s plan to phase out animal testing requirement for monoclonal antibodies and other drugs with more human-relevant methods
Areas to 168体彩幸运官网最新入口
New approach methodologies (168网址官网网页 - 飞行艇幸运历史记录走势体彩), including 飞艇历史记录查询结果号码 (OOC), represent the key to faster, more accurate drug discovery. Explore how to harness the power of 168体育官网全国历史号码查询® OOC in your lab, or via our contract research services.
Products
Learn more about PhysioMimix and why it’s helping drive OOC adoption
Applications
Explore the varying application areas that PhysioMimix OOC helps support
Technology
Discover why the technology that powers PhysioMimix is like no other
PhysioMimix® 飞艇历史记录查询结果号码
Our 全天计划精准飞艇、记录历史查询结果、168体彩网历史号码 systems model human-specific biology, which animals lack. Detect effects that manifest only in human tissue to improve the accuracy and efficiency of drug discovery.
- Human-relevant, translatable data
- Single- and multi-organ capabilities
- Flexible and customizable
- Easy to adopt, simple to use
- Broad drug modality compatibility, including monoclonal antibodies, oligonucleotides and traditional small molecules
10+
years of OOC industry experience and know how
70%
of our employees are scientists and engineers
16/20
top pharmaceutical companies use PhysioMimix®
What’s new?
Resources
New Scientific publication
A primary human Gut/Liver microphysiological system to estimate human oral bioavailability…
Industry news
3Rs 查询最新结果和幸运直播开奖官网开奖计划 with FDA
CN Bio to participate in 3Rs 查询最新结果和幸运直播开奖官网开奖计划-lead project with FDA to build confidence in Liver MPS for DILI…
Partnerships
PhysioMimix data for Inipharm
PhysioMimix® Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment…
Press release
New ADME service launch
CN Bio adds computational modelling capabilities to ADME services for enhanced bioavailability profiling…